Switch to:
Genomic Health Inc (NAS:GHDX)
EV/EBITDA
-25.35 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Genomic Health Inc's enterprise value is $774.2 Mil. Genomic Health Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2015 was $-30.5 Mil. Therefore, Genomic Health Inc's EV/EBITDA ratio for today is -25.35.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Genomic Health Inc's stock price is $27.52. Genomic Health Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2015 was $-0.99. Therefore, Genomic Health Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Genomic Health Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=774.227/-30.541
=-25.35

Genomic Health Inc's current Enterprise Value is $774.2 Mil.
Genomic Health Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2015 was -4.128 (Sep. 2014 ) + -4.314 (Dec. 2014 ) + -12.941 (Mar. 2015 ) + -9.158 (Jun. 2015 ) = $-30.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Genomic Health Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=27.52/-0.987
=

Genomic Health Inc's share price for today is $27.52.
Genomic Health Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2015 was -0.2 (Sep. 2014 ) + -0.197 (Dec. 2014 ) + -0.3 (Mar. 2015 ) + -0.29 (Jun. 2015 ) = $-0.99.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Genomic Health Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -6.58-15.40-22.38-46.30-235.2747.7141.9051.54-145.40-54.69

Genomic Health Inc Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebitda 62.17111.02167.03-145.40-62.10-57.57-40.93-54.69-35.23-25.64
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK